HKEX Stock Code: 01093English|繁體|简体
Financial Summary
  For the year ended 31 December
  2019
RMB'000
 
2020
RMB'000
 
2021
RMB'000
 
2022
RMB'000
 
2023
RMB'000
 
Results          
Revenue 22,103,192 24,942,204 27,866,870 30,936,904 31,450,109
Profit before tax 4,626,162 6,391,023 6,847,096 7,582,261 7,389,372
Income tax expense (892,810) (1,162,013) (1,158,972) (1,350,211) (1,316,679)
           
Profit for the year 3,733,352 5,229,010 5,688,124 6,232,050 6,072,693
           
Profit for the year attributable to:          
   Owners of the company 3,714,106 5,159,655 5,605,185 6,091,390 5,873,325
   Non-controlling interests 19,246 69,355 82,939 140,660 199,368
           
  3,733,352 5,229,010 5,688,124 6,232,050 6,072,693
           
  RMB cents
(Restated)
(Noted)
RMB cents RMB cents RMB cents RMB cents
Earnings per share          
   — Basic 31.07 43.16 46.89 51.11 49.47
           
   — Diluted 31.07 43.16 46.89 51.11 49.47



  As at 31 December
  2019
RMB'000
 
2020
RMB'000
 
2021
RMB'000
 
2022
RMB'000
 
2023
RMB'000
 
Assets and liabilities          
Total assets 26,318,322 30,070,206 34,741,576 41,769,774 46,282,170
Total liabilities (6,800,157) (6,969,133) (7,913,345) (10,127,899) (11,264,158)
         
Net assets 19,518,165 23,101,073 26,828,231 31,641,875 35,018,012
         
Equity attributable to owners of the Company 18,461,723 22,332,288 25,986,672 30,197,534 33,203,208
Non-controlling interests 1,056,442 768,785 841,559 1,444,341 1,814,804
         
Total equity 19,518,165 23,101,073 26,828,231 31,641,875 35,018,012
Note: The earnings per share has been adjusted for the effect of the bonus issues on 3 July 2020 and 29 October 2020.
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.